Contemporary grading for prostate cancer: implications for patient care.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerEvaluation and prognostic significance of ACAT1 as a marker of prostate cancer progressionDiscovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyPredominance of ERG-negative high-grade prostate cancers in African American men.Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.Active surveillance for the management of localized prostate cancer: Guideline recommendationsShould Gleason 6 be labeled as cancer?HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.Extracellular vesicles in prostate cancer: new future clinical strategies?Predicting the Gleason sum of a patient with a prostate biopsy core Gleason ≤7 and a prostate biopsy core Gleason ≥8.Prostate cancer: from Gleason scoring to prognostic grade grouping.Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study.Gleason inflation 1998-2011: a registry study of 97,168 men.Machine learning approaches to analyze histological images of tissues from radical prostatectomies.Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomographyLow-Risk Prostate Cancer and Tumor Upgrading in the Surgical Specimen: Analysis of Clinical Factors Predicting Tumor Upgrading in a Contemporary Series of Patients Who were Evaluated According to the Modified Gleason Score Grading System.Changes in preoperative characteristics in patients undergoing radical prostatectomy--a 16-year nationwide analysis.Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness.Assessment of the need for DCE MRI in the detection of dominant lesions in the whole gland: Correlation between histology and MRI of prostate cancer.Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.A Multi-scale U-Net for Semantic Segmentation of Histological Images from Radical Prostatectomies.
P2860
Q26738703-C2F0A515-DAFA-4686-BB25-302CD8DBE1DDQ28303423-F0DD1D48-681C-412A-A4E1-B1F8DC8AF023Q28534277-A37687E3-3F17-40CF-8354-E2E49B6E1F0DQ34265721-9CFE56B7-678B-467D-8628-F8FDE2F6E094Q34448925-22B34B83-29BC-421F-86EB-613527829879Q35678391-A1D2246D-A6BA-416E-A3B1-C719F08A0FF9Q35725546-3F6253A9-A8C5-4877-9087-3BA24AB0E46BQ36931932-A41033BD-4993-43F0-B794-EDCBA730E497Q37582166-B5DCE355-5D4D-4992-A129-6FD52065FA2CQ37632337-5900A28A-E78D-4947-BD24-D12D21A2F54CQ38240855-0A74C02F-5AA3-48D4-B52C-9BF5843D3567Q38786316-DB4AE0B7-8CA5-4EA0-9D5E-2D9A0952CB63Q39029690-F274E2B3-66EE-4359-9EA3-DDC9913072EFQ39199397-407F80C0-EC82-46E0-9AFE-A620EDA1FABAQ40312523-D73DEE1C-5466-4840-B185-47B79A8269A5Q40740935-70E153CB-9AD6-4266-A326-32A0F024880CQ41601490-65CFF3CB-BFF7-43CA-89CF-648CEA99E67BQ43595827-D8C0C517-A57B-4DDE-87C7-347A0A363492Q45412370-2EF1333B-7F0C-41FB-9095-828DE1795152Q48367635-BF2CBCF1-39A7-4E36-A0D4-B605DF126635Q53632909-300BB680-0E90-4ED3-A4D1-D155FCE869FEQ55428679-5C8D110D-6EA3-450C-A11E-558A9809C169
P2860
Contemporary grading for prostate cancer: implications for patient care.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Contemporary grading for prostate cancer: implications for patient care.
@en
type
label
Contemporary grading for prostate cancer: implications for patient care.
@en
prefLabel
Contemporary grading for prostate cancer: implications for patient care.
@en
P2093
P50
P1433
P1476
Contemporary grading for prostate cancer: implications for patient care.
@en
P2093
Andreas Erbersdobler
Daniel W Lin
Fadi Brimo
Joel B Nelson
Jonathan I Epstein
Mahul Amin
Theo van der Kwast
P304
P356
10.1016/J.EURURO.2012.10.015
P407
P577
2012-10-17T00:00:00Z